Haematological Malignancy research hub
6 indexed studies · 5 currently recruiting
- not yet recruitingPHASE2, PHASE3
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
This study looks at two drugs called dabrafenib and trametinib for various cancers with a specific gene change (BRAF V600). These drugs are already approved for some cancers and researchers want to see if they can help people with other rare cancers or cancers with this same change.
United Kingdom - recruiting
Electroporation for Cancer Treatment Real World Registry
This study looks at how well a treatment called electroporation works for skin and gut cancers in everyday life. It checks how often tumours shrink, if they come back, and any side effects people experience. It helps understand the long-term effects of this treatment.
United Kingdom - active not recruitingPHASE2
A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)
This study is looking for new ways to treat certain advanced gastrointestinal (GI) cancers. It tests a new medicine called raludotatug deruxtecan (R-DXd). Researchers want to see if this medicine can shrink or get rid of the cancer.
United States · Argentina · Canada - recruitingPHASE2
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
This study looks at a medicine called atezolizumab for different cancers. We want to see if a special test of your cancer cells can predict if the medicine will work well for you. This helps us learn more about tailoring treatments.
Canada - recruitingNA
PSMA in Gastroenterologic Tumors (GIPSMA)
This study looks at a special scan called PSMA PET/CT for people with newly diagnosed stomach or gut cancers. It aims to see if this scan can better find cancer spots and predict how well treatments might work, by looking for a marker called PSMA on their tumours.
Germany - recruiting
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
The SHERLOCK study aims to find tiny bits of cancer DNA in your blood after treatment. This helps doctors spot if cancer might return early, hoping to improve long-term health. We're looking for new ways to track different types of cancer.
Canada